Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nitto Medic is a Japanese specialty pharmaceutical company focused on ophthalmic medicines, particularly eye drops and ophthalmic ointments, with additional activity in dermatology-related external preparations and contract manufacturing. The company manufactures, sells, exports, and imports pharmaceutical products and related medical supplies, and it operates licensed pharmaceutical manufacturing and marketing businesses in Japan. Its business appears centered on commercialized products rather than a classic innovative clinical biotech pipeline, with notable products including ophthalmic anti-infectives such as Tosflo Ophthalmic Solution 0.3%, Vancomycin Ophthalmic Ointment 1%, and Aciclovir Ophthalmic Ointment 3%. Nitto Medic emphasizes advanced aseptic production, integrated manufacturing-to-delivery operations, and export expansion, especially into Asian markets. The company also offers contract manufacturing and contract testing services for investigational and pharmaceutical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nitto Medical.